Evidence map›Paper›PMID 42268403›Full record

ArticleEuropean journal of nuclear medicine and molecular imaging2026

Identifing two distinct cortical progression subtypes of Parkinson's disease through multimodal neuroimaging.

Qinwei Yu, Xueyi Guan, Jinfeng Wu, Xun Sun, Quan Chen, Danfang Yu, Long Liu, Guiying Kuang, Jingwen Li, Xinyu Hu and 7 more

Abstract read
PubMed Publisher
In one paragraph

Article in European journal of nuclear medicine and molecular imaging, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Qinwei Yu *Department of Neurology, Tongji Medical College, Union Hospital, Huazhong University of Science and Technology, Wuhan, Hubei, 430022, People's Republic of China.
Xueyi Guan *Department of Radiology, Shanghai Key Laboratory of Emotions and Affective Disorders, Songjiang Research Institute, Songjiang Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 201600, P. R. China.
Jinfeng Wu *Department of Radiology, Shanghai Key Laboratory of Emotions and Affective Disorders, Songjiang Research Institute, Songjiang Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 201600, P. R. China.
Xun Sun *Department of Nuclear Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, No. 1277 Jiefang Avenue, Wuhan, 430022, China.
Quan ChenHubei Key Laboratory of Molecular Imaging, Wuhan, 430022, China.
Danfang YuDepartment of Neurology, Wuhan Red Cross Hospital, 392 Hongkong Road, Wuhan, Hubei, China.
Long LiuDepartment of Neurology, Wuhan Red Cross Hospital, 392 Hongkong Road, Wuhan, Hubei, China.
Guiying KuangDepartment of Neurology, Tongji Medical College, Union Hospital, Huazhong University of Science and Technology, Wuhan, Hubei, 430022, People's Republic of China.
Jingwen LiDepartment of Neurology, Tongji Medical College, Union Hospital, Huazhong University of Science and Technology, Wuhan, Hubei, 430022, People's Republic of China.
Xinyu HuDepartment of Neurology, Tongji Medical College, Union Hospital, Huazhong University of Science and Technology, Wuhan, Hubei, 430022, People's Republic of China.
Hoiyin CheungDepartment of Anesthesiology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Fanyong XuDepartment of Radiology, Shanghai Key Laboratory of Emotions and Affective Disorders, Songjiang Research Institute, Songjiang Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 201600, P. R. China.
Jian GongDepartment of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
Fei DuMcLean Imaging Center, McLean Hospital, Harvard Medical School, Belmont, MA, 02478, USA.
Xiaoli LanDepartment of Nuclear Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, No. 1277 Jiefang Avenue, Wuhan, 430022, China. lxl730724@hotmail.com.
Nian XiongDepartment of Neurology, Tongji Medical College, Union Hospital, Huazhong University of Science and Technology, Wuhan, Hubei, 430022, People's Republic of China. nianxiong@hust.edu.cn.
Jie WangDepartment of Radiology, Shanghai Key Laboratory of Emotions and Affective Disorders, Songjiang Research Institute, Songjiang Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 201600, P. R. China. jie.wang@shsmu.edu.cn.

Funding

Major Research Plan Major Research PlanNational Natural Science Foundation of China 82271278National Natural Science Foundation of China NSFC81701759Natural Science Foundation of Hubei Province 2023020601012303Natural Science Foundation of Hubei Province 2023AFB970Natural Science Foundation of Hubei Province JCZRYB202501288Wuhan Science and Technology Project Wuhan Science and Technology Project
6 · The paper itself

Abstract

purposeTo investigate whether distinct patterns of cortical involvement exist in Parkinson's disease (PD) and to characterize their potential progression trajectories using multimodal neuroimaging and data-driven disease progression modeling.

methodsIn this cross-sectional multimodal imaging study, we enrolled 317 patients with clinically diagnosed PD and 61 healthy controls. All participants underwent simultaneous FDG-PET and MRI scanning. We applied the Subtype and Stage Inference (SuStaIn) model to cortical glucose metabolism and thickness data to identify latent disease progression patterns. Network-level characteristics were further examined within a whole-brain gradient framework. Robustness was assessed through age- and sex-balanced sensitivity analyses in the local cohort and external validation using harmonized T1-weighted MRI data from the Parkinson's Progression Markers Initiative (PPMI) dataset.

resultsTwo distinct cortical involvement subtypes were identified. One subtype showed predominant alterations in higher-order association networks, including the default mode and frontoparietal networks, whereas the other was characterized by greater involvement of lower-order sensorimotor and limbic systems. These subtype patterns remained stable across sensitivity analyses and external validation. Disease duration showed a significant correlation with the inferred disease stage (r = 0.15, p = 0.01). Imaging findings further revealed hypermetabolism in brainstem and trans-entorhinal regions accompanied by widespread cortical hypometabolism.

conclusionsOur findings reveal two robust cortical progression patterns in PD, highlighting substantial heterogeneity in network-level metabolic and structural involvement. This framework provides new insights into PD phenotypic variability and may support future efforts toward disease stratification and personalized research.

Indexed as

Cerebral CortexDisease ProgressionMultimodal ImagingNeuroimagingParkinson DiseaseAgedCase-Control StudiesCross-Sectional StudiesFemaleHumansMagnetic Resonance ImagingMaleMiddle AgedPositron-Emission TomographyBrain network analysisMachine learningMultimodal neuroimagingParkinson's disease subtypes

Identifiers

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.